In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean ...
More therapies, temperature requirements, clients, and services are creating new pressure on pharmaceutical and life sciences distribution operations. This webinar helps leaders recognize when their ...
Octapharma USA's Kerem Tokel, a LogiPharma USA 2026 freight security panelist, discusses theft hotspots, the export of stolen ...
DOL's final rule requires PBMs to disclose rebates and formulary incentives to large self-insured plans for plan years ...
Foreign-trade zones allow pharma companies to hold imported inventory closer to U.S. demand while deferring duties and keeping market allocation open.
In this week’s Pharma Pulse, GoodRx expands an employer offering built on manufacturer pricing for GLP-1 obesity drugs, a ...
Why outdated paper prescribing information is creating unnecessary cost, complexity and friction across a modern ...
Jon Hamrick, partner at Curatio Advisors, discusses how product attributes, company size and stakeholder alignment shape pharma commercialization strategy. Curatio Advisors starts its ...